Article
Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients.
PloS one - 26 Jan 2010
Ugo Valerie, Tondeur Sylvie, Menot Marie-Laurence, Bonnin Nadine, Le Gac Gerald, Tonetti Carole, Mansat-De Mas Veronique, Lecucq Lydie, Kiladjian Jean-Jacques, Chomienne Christine, Dosquet Christine, Parquet Nathalie, Darnige Luc, Porneuf Marc, Escoffre-Barbe Martine, Giraudier Stephane, Delabesse Eric, Cassinat Bruno
Abstract excerpt
BACKGROUND: Myeloproliferative disorders are characterized by clonal expansion of normal mature blood cells. Acquired mutations giving rise to constitutive activation of the JAK2 tyrosine kinase has been shown to be present in the majority of patients. Since the demonstration that the V617F mutat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
